Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Penumbra (PEN) PT Raised to $165 at Canaccord Genuity
-
Shopify (SHOP) PT Raised to $160 at Canaccord Genuity
-
Quidel Corp. (QDEL) PT Raised to $65 at Canaccord Genuity
-
Canadian Banc Corp. Announces Overnight Offering
-
Helios and Matheson (HMNY) Provides Financial Update
-
Golden Leaf Holdings to Present at Canaccord Genuity's 2nd Annual Cannabis Conference
-
Canaccord Genuity Upgrades Impinj Inc (PI) to Buy
-
Nevro Corp (NVRO) PT Lowered to $102 at Canaccord Genuity
-
Tactile Systems Technology (TCMD) PT Raised to $46 at Canaccord Genuity
-
Everbridge (EVBG) PT Raised to $46 at Canaccord Genuity
-
Premier, Inc. (PINC) PT Lowered to $37 at Canaccord Genuity
-
Zillow Group (ZG) PT Raised to $60 at Canaccord Genuity
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Reis, Inc. Announces First Quarter 2018 Financial Results
-
Reis, Inc. Announces First Quarter 2018 Financial Results
-
Canaccord Genuity Starts Zuora Inc. (ZUO) at Hold
-
IDEXX Laboratories (IDXX) PT Raised to $225 at Canaccord Genuity
-
Heska Corp. (HSKA) PT Raised to $100 at Canaccord Genuity
-
HMS Holdings (HMSY) PT Raised to $21 at Canaccord Genuity
-
Canaccord Genuity Downgrades Fluor (FLR) to Hold, 'Execution Issues Push Us To The Sidelines'
-
Lexington Announces Brokered Private Placement
-
Canaccord Genuity Starts Algonquin Power & Utilities Corp. (AQN) at Buy
-
Canaccord Genuity Assumes TransAlta (TAC) at Hold
-
Insulet Corporation (PODD) PT Raised to $96 at Canaccord Genuity
-
Appian Corp. (APPN) PT Raised to $28 at Canaccord Genuity
-
OraSure Technologies (OSUR) PT Lowered to $20 at Canaccord Genuity
-
Pandora (P) PT Raised to $8 at Canaccord Genuity
-
Genomic Health Inc. (GHDX) PT Raised to $41 at Canaccord Genuity
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results:
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
-
Smith & Nephew (SNN) PT Lowered to $42 at Canaccord Genuity
-
Sientra (SIEN) Prices 7.41M Share Offering at $13.50
-
Sientra Announces Pricing of Upsized Public Offering of Common Stock
-
ConforMIS (CFMS) PT Lowered to $3.50 at Canaccord Genuity
-
Karyopharm Therapeutics (KPTI) Prices 9.15M Share Common Offering at $14.75/Sh
-
Canaccord Genuity Downgrades Hologic (HOLX) to Hold
-
Canaccord Genuity Upgrades Clean Harbors (CLH) to Buy
-
Bandwidth Inc. (BAND) PT Raised to $40 at Canaccord Genuity
-
Belden, Inc. (BDC) PT Lowered to $88 at Canaccord Genuity
-
Spirit AeroSystems (SPR) PT Lowered to $105 at Canaccord Genuity
-
Qorvo Inc (QRVO) PT Raised to $86 at Canaccord Genuity
-
Cerner (CERN) PT Lowered to $64 at Canaccord Genuity
-
DexCom (DXCM) PT Raised to $85 at Canaccord Genuity
-
STAAR Surgical (STAA) PT Raised to $23 at Canaccord Genuity
-
Globus Medical (GMED) PT Raised to $58 at Canaccord Genuity
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock

